Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Real Estate · ·
$37.54
▼ $0.63 (-1.7%)
Market data updated: 09/20 06:30 PM
Fundamentals updated: 09/20/2026
News analyzed: 09/20/2026
Market Cap
$8.87B
Day Range
$37.39 - $38.14
52-Week Range
$32.79 - $43.62
Beta
—
Next Earnings
03.11.2026
Support
$37.38
Resistance
$43.62
CTRE is a stock from the Real Estate sector — REITs and real-estate companies — highly sensitive to interest rates and property prices.
+8.2% (1Y)
Strengths: 7/24 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Revenue growth (last year)
Revenue growth (last year): 60.8%
Growth
Biggest negative driver
Price vs. SMA 50
Price is below the 50-day average
Technical
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
52
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
74
Quality
55
Value
50
Momentum
13
Risk
56
Sentiment
98
Fundamental
59
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of CareTrust REIT, Inc. (CTRE) has centered on its strong fiscal Q2 2026 performance, including higher-than-expected revenues and an upward revision to its full-year 2026 normalized FFO per share guidance, aligning with analyst expectations. Analysts like Wells Fargo maintained an "Overweight" rating but adjusted the price target downward to $44 from $47. The company’s acquisition growth and focus on healthcare REITs have also drawn attention, alongside discussions on its valuation compared to peers like FVR. Mixed analyst sentiment, including a downgrade by RBC Capital, reflects cautious optimism amid market comparisons and growth projections.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about CareTrust REIT, Inc.. News trend score: 98. Reason: 12 of the last 20 articles are positive, versus 4 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
24
🎯 Conviction (vs. Emotion)
40
Psychology
92
Fundamentals
59
Technical
13
Valuation
50
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price (3M)
+1%
Market Narrative
56
Fundamental Reality
40
Narrative Gap
+16
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The data reveals a **narrative-reality gap (13 points)** and a dominant **anchoring bias (29/100)**, where traders may be fixated on the 3.6% proximity to support. Low momentum (-1.0% ROC), neutral RSI (44), and modest volume (0.66x avg) suggest neither FOMO nor panic is driving behavior. The absence of herding or euphoria implies detached, cautious positioning. The key question: *Will traders break support or hold near-term levels?*
Updated: 09/09/2026, 04:50 AM
What could change this?
👥 What the crowd believes
"Could CareTrust (CTRE) Stock Be a Top Healthcare REIT as Acquisition Growth Accelerates?"
"CareTrust reported total revenues of $161.34 [...] raising its full-year 2026 guidance to $2.03 to $2.06 normalized FFO per share"
"CareTrust REIT Well Positioned to Deploy Capital Accretively, RBC Says"
"Wells Fargo maintains CareTrust REIT with an Overweight rating but lowers price target from $47 to $44"
📈 11D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Philip Fisher — 100/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 4/100
🗣️ Why do they disagree?
This stock sparks a sharp divide between fundamental growth advocates and more conservative or market-skeptical methodologies. Philip Fisher, Peter Lynch, and Edgar Lawrence Smith all rate it a perfect 100, seeing it as a rare high-quality, long-term compounder—Fisher highlights exceptional company quality, while Lynch and Smith emphasize its undervalued growth potential. Meanwhile, Walter Bagehot’s near-perfect score suggests strong fundamentals, though his lack of balance-sheet clarity keeps him from full endorsement. In contrast, the market-efficiency camp (Malkiel/Bogle) and Graham’s strict valuation rules dismiss it outright, with the Enterprising Investor variant scoring it a dismal 1, calling it too expensive even for risk-tolerant buyers. Cyclical and trend-based investors like Nelson and Livermore split further: Nelson sees a favorable cycle position, while Livermore’s low score reflects a negative trend, illustrating how momentum and timing clash with growth optimism. Even among value-oriented thinkers like Marks and Veblen, the verdicts vary—Marks finds the risk reasonable, while Veblen aligns growth with real value, but neither fully embraces the stock’s speculative appeal.
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟢 100
Exceptional company quality by Fisher's standards
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 35%
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 100
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 100
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 99
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟢 98
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 76
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 74
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 67
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 66
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 61
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 59
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 52
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 46
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 43
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 16
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 4
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Based on the last 282 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (0 bullish · 10 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
67.3%
EBITDA Margin
—
ROE
7.9%
ROA
6.2%
ROIC
—
EPS
$1.57
Cash
$198.04M
Total Debt
$894.22M
Current Ratio
—
Debt/Equity
0.22
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 30.6.2026 | $0.390 |
| 29.6.2026 | $0.390 |
| 31.3.2026 | $0.390 |
| 30.3.2026 | $0.390 |
| 31.12.2025 | $0.335 |
| 30.12.2025 | $0.335 |
| 30.9.2025 | $0.335 |
| 29.9.2025 | $0.335 |
| 30.6.2025 | $0.335 |
| 29.6.2025 | $0.335 |
| 31.3.2025 | $0.335 |
| 30.3.2025 | $0.335 |
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$19.77
Tangible Book Value per Share (Tangible NAV)
$19.53
Sentiment based on basic keywords (not AI) — 12 positive, 4 neutral, 4 negative out of the last 20 articles.
SeekingAlpha · 20.9.2026
SeekingAlpha · 18.9.2026
Yahoo · 17.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 15.9.2026
Yahoo · 15.9.2026
Benzinga · 15.9.2026
SeekingAlpha · 13.9.2026
SeekingAlpha · 13.9.2026
MT Newswires · 10.9.2026
Benzinga · 1.9.2026
SeekingAlpha · 29.8.2026
Yahoo · 28.8.2026
Insider Monkey · 28.8.2026
Yahoo · 26.8.2026
Zacks · 26.8.2026
SeekingAlpha · 18.8.2026
SeekingAlpha · 16.8.2026
Fintel · 15.8.2026
CareTrust REIT, Inc. (CTRE) currently has a StockIQ AI score of 52/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
CTRE currently scores 52/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
CTRE's technical score is 13/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Revenue growth (last year): 60.8%; Earnings per share (EPS) growth: 96.3%; Net income growth: 156.3%.
Based on the real signals StockIQ computed: Price is below the 50-day average; Price is below the 200-day average; MACD histogram is negative — falling momentum.
Yes — CTRE has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| BEALE LAUREN | Tax Withholding in Shares | 31.1.2026 | 12,208 | -12,208 | $37.34 |
| Sedgwick David M. | Grant/Award from Employer | 31.1.2026 | 99,240 | +99,240 | — |
| Sedgwick David M. | Tax Withholding in Shares | 31.1.2026 | 114,274 | -114,274 | $37.34 |
| Callister James | Tax Withholding in Shares | 31.1.2026 | 46,267 | -46,267 | $37.34 |
| Callister James | Grant/Award from Employer | 31.1.2026 | 58,379 | +58,379 | — |
| Sedgwick David M. | Grant/Award from Employer | 31.1.2026 | 545,383 | +99,240 | — |
| Sedgwick David M. | Tax Withholding in Shares | 31.1.2026 | 431,109 | -114,274 | $37.34 |
| Callister James | Grant/Award from Employer | 31.1.2026 | 164,017 | +58,379 | — |
| Callister James | Tax Withholding in Shares | 31.1.2026 | 117,750 | -46,267 | $37.34 |
| BEALE LAUREN | Tax Withholding in Shares | 31.1.2026 | 70,006 | -12,208 | $37.34 |
| Plumb Spencer G | Grant/Award from Employer | 2.1.2026 | 5,781 | +5,781 | — |
| BEALE LAUREN | Grant/Award from Employer | 2.1.2026 | 11,133 | +11,133 | — |
| Stapley Gregory K. | Grant/Award from Employer | 2.1.2026 | 5,781 | +5,781 | — |
| Callister James | Grant/Award from Employer | 2.1.2026 | 23,838 | +23,838 | — |
| Bunker Derek J | Grant/Award from Employer | 2.1.2026 | 11,145 | +11,145 | — |
| Sedgwick David M. | Grant/Award from Employer | 2.1.2026 | 73,821 | +73,821 | — |
| Williams Careina D. | Grant/Award from Employer | 2.1.2026 | 3,105 | +3,105 | — |
| LAING DIANA | Grant/Award from Employer | 2.1.2026 | 3,105 | +3,105 | — |
| Olson Anne | Grant/Award from Employer | 2.1.2026 | 3,105 | +3,105 | — |
| LAING DIANA | Grant/Award from Employer | 2.1.2026 | 3,105 | +3,105 | — |
| Sedgwick David M. | Grant/Award from Employer | 2.1.2026 | 73,821 | +73,821 | — |
| Stapley Gregory K. | Grant/Award from Employer | 2.1.2026 | 5,781 | +5,781 | — |
| Plumb Spencer G | Grant/Award from Employer | 2.1.2026 | 5,781 | +5,781 | — |
| Callister James | Grant/Award from Employer | 2.1.2026 | 23,838 | +23,838 | — |
| Bunker Derek J | Grant/Award from Employer | 2.1.2026 | 11,145 | +11,145 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
15,432,408 shares short as of 2026-08-31 · vs. 24,289,020 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
46.2% of trading volume this week was short selling, vs. 42.2% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology